Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Iron is essential for proliferation of normal and neoplastic cells. Cellular iron uptake, utilization and storage are regulated by transcriptional and post-transcriptional mechanisms. We hypothesized that the disruption of iron homeostasis may modulate the growth properties of cancer cells. To address this, we employed H1299 lung cancer cells engineered for tetracycline-inducible overexpression of the post-transcriptional regulator iron regulatory protein 1 (IRP1). The induction of IRP1 (wild-type or the constitutive IRP1(C437S) mutant) did not affect the proliferation of the cells in culture, and only modestly reduced their efficiency to form colonies in soft agar. However, IRP1 dramatically impaired the capacity of the cells to form solid tumor xenografts in nude mice. Tumors derived from IRP1-transfectants were <20% in size compared to those from parent cells. IRP1 coordinately controls the expression of transferrin receptor 1 (TfR1) and ferritin by binding to iron-responsive elements (IREs) within their mRNAs. Biochemical analysis revealed high expression of epitope-tagged IRP1 in tumor tissue, which was associated with a profound increase in IRE-binding activity. As expected, this response misregulated iron metabolism by increasing TfR1 levels. Surprisingly, IRP1 failed to suppress ferritin expression and did not affect the levels of the iron transporter ferroportin. Our results show that the overexpression of IRP1 is associated with an apparent tumor suppressor phenotype and provide a direct regulatory link between the IRE/IRP system and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TFR1 is also expressed by neoplastic cells in solid tumors and hematologic malignancies, including chronic lymphocytic leukemia, suggesting that inflammation associated with malignant diseases may also limit iron availability for cancer cells [49, 50].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [49]
Citations
Cites
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Molecular mechanisms of translational control
Gebauer, F., & Hentze, M. W. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1488 · Cited by 991
Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid medium
Freedman, V (1974) · Cell · doi:10.1016/0092-8674(74)90050-6 · Cited by 806
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, M., Raleigh, J., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600777 · Cited by 729
ROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600
Arosio, P., & Levi, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00842-0 · Cited by 542
Iron Metabolism and the IRE/IRP Regulatory System: An Update
PANTOPOULOS, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.001 · Cited by 512
Self-citationThe role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Eaton, J. W., & Qian, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00772-4 · Cited by 389
Cited by
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Regulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986
Self-citationThe genetic basis of kidney cancer: a metabolic disease
Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 744
“(40;41) Overexpression of IRP1 suppresses growth of lung tumor xenografts, (42) which has prompted the search for small molecules that could decrease HIF2-α translation by enhancing the binding of IRP1 to the 5’ untranslated region of its mRNA.”
BackgroundMammalian iron metabolism and its control by iron regulatory proteins
Anderson, C. P., Shen, M., Eisenstein, R. S., & Leibold, E. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.010 · Cited by 493
“By contrast, overexpression of IRP1 in H1299 lung cancer cells suppressed tumor xenograft growth in mice [177].”
BackgroundFerroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448
The IRP/IRE system in vivo: insights from mouse models
Wilkinson, N., & Pantopoulos, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00176 · Cited by 366
“Thus, overexpression of IRP1 or a constitutive IRP1 mutant in human H1299 lung cancer cells impaired tumor xenograft growth in nude mice (Chen et al., 2007).”
BackgroundSelf-citationAltered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
Brown, R. A. M., Richardson, K. L., Kabir, T. D., Trinder, D., Ganss, R., & Leedman, P. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00476 · Cited by 278
“In human lung cancer cells with inducible IRP1 overexpression there was no impact on proliferation in vitro, but when implanted in vivo had suppressed tumor growth (128).”
BackgroundENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1
Zhang, T., Sun, L., Hao, Y., Suo, C., Shen, S., Wei, H., Ma, W., Zhang, P., Wang, T., Gu, X., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00299-1 · Cited by 203
“Our data showed that IRP1 C437S , the enzymatically inactive mutation of IRP1 38 , exhibited similar effect as the wild-type IRP1 on Mfrn1 expression and cell proliferation (Extended Data Fig.”
Cho, H.-H., Cahill, C. M., Vanderburg, C. R., Scherzer, C. R., Wang, B., Huang, X., & Rogers, J. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149161 · Cited by 183
Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3614 · Cited by 158
“suppression rather than growth of tumor xenografts (15).”
BackgroundResultNairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
“Unexpectedly, overexpression of IRP1 impairs the growth of lung cancer cells transplanted into nude mice despite increased TFR1 levels (55).”
BackgroundIron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
Zhang, C., & Zhang, F. (2015) · Protein & Cell · doi:10.1007/s13238-014-0119-z · Cited by 147
“However, overexpression of IRP1 or IRP1C437S dramatically suppresses the growth of tumor xenografts in nude mice (Chen et al., 2007), providing a direct regulatory link between the IRE/IRP system and cancer.”
BackgroundIRP2 Regulates Breast Tumor Growth
Wang, W., Deng, Z., Hatcher, H., Miller, L. D., Di, X., Tesfay, L., Sui, G., D'Agostino, R. B., Torti, F. M., & Torti, S. V. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1224 · Cited by 137
“However, we note that effects of IRP1 in vitro do not always mirror their effects in vivo (53), and it remains possible that IRP1 may contribute to iron metabolism and/or breast tumor growth in vivo.”
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
Recalcati, S., Minotti, G., & Cairo, G. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2983 · Cited by 122
“…not completely understood, as is shown by the previously mentioned studies indicating that IRP1 overexpression efficiently suppresses tumor growth (24), whereas the overexpression of IRP2 stimulates it ( These different results can be reconciled by considering that the expression of IRP1 and IRP2…”
Iron: An Essential Element of Cancer Metabolism
Hsu, M. Y., Mina, E., Roetto, A., & Porporato, P. E. (2020) · Cells · doi:10.3390/cells9122591 · Cited by 126
Iron homeostasis in breast cancer
Marques, O., da Silva, B. M., Porto, G., & Lopes, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.029 · Cited by 127
“[148].”
Rychtarcikova, Z., Lettlova, S., Tomkova, V., Korenkova, V., Langerova, L., Simonova, E., Zjablovskaja, P., Alberich-Jorda, M., Neuzil, J., & Truksa, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14093 · Cited by 100
MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis
Kindrat, I., Tryndyak, V., de Conti, A., Shpyleva, S., Mudalige, T., Kobets, T., Еrstenyuk, H. M., Beland, F. A., & Pogribny, I. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6004 · Cited by 100
“Additionally, it has been demonstrated that the IRP2 binding activity is selectively activated by low iron, positively correlated with a TFRC expression [36], and the induction of IRP2 promoted tumor growth [37], while up-regulation of IRP1 exhibited a tumor suppressive effect [38].”
‘Ride on the ferrous wheel’ – The cycle of iron in macrophages in health and disease
Nairz, M., Schroll, A., Demetz, E., Tancevski, I., Theurl, I., & Weiss, G. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.09.010 · Cited by 89
Phaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 76
Maffettone, C., Chen, G., Drozdov, I., Ouzounis, C., & Pantopoulos, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010163 · Cited by 70
“Similar unexpected findings were previously documented in tumor xenografts overexpressing IRP1 [19], while the overexpression of IRP1 only conditionally suppressed ferritin mRNA translation in cultured H1299 cells grown at low densities [21].”
BackgroundMethodResultInfluentialSelf-citationChen, Q., Wang, L., Ma, Y., Wu, X., Jin, L., & Yu, F. (2013) · Thoracic Cancer · doi:10.1111/1759-7714.12046 · Cited by 75
p53 tumor suppressor and iron homeostasis
Zhang, J., & Chen, X. (2018) · FEBS Journal · doi:10.1111/febs.14638 · Cited by 66
Mice are poor heme absorbers and do not require intestinal Hmox1 for dietary heme iron assimilation
Fillebeen, C., Gkouvatsos, K., Fragoso, G., Calvé, A., Garcia‐Santos, D., Buffler, M., Becker, C., Schümann, K., Ponka, P., Santos, M. M., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.126870 · Cited by 48
“Tissue total (heme and non-heme) iron content was measured by atomic absorption spectroscopy (3, 4).”
MethodSelf-citationYang, X. R., Liang, X. S., Pfeiffer, R. M., Wheeler, W., Maeder, D. L., Burdette, L. A., Yeager, M., Chanock, S. J., Tucker, M. A., & Goldstein, A. M. (2010) · Familial Cancer · doi:10.1007/s10689-010-9356-3 · Cited by 45
“Overexpression of IRP1 has been observed to suppress tumor formation in xenografts, suggesting a direct link between IRP1 and cancer [44].”
Thompson, L. R., Oliveira, T. G., Hermann, E. R., Chowanadisai, W., Clarke, S. L., & Montgomery, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186751 · Cited by 46
“As mentioned above, increased expression of TFRC is typically mediated by increased IRP mRNA binding activity, but overexpression of IRP1 was actually found to decrease tumor growth in vivo [12].”
BackgroundIron: Key player in cancer and cell cycle?
Khan, A., Singh, P., & Srivastava, A. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126582 · Cited by 46
Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1
Lorenz, F., Pawłowicz, E., Klimkowska, M., Beshara, S., Brustad, A. B., Skotnicki, A. B., Wåhlin, A., & Machaczka, M. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.10.010 · Cited by 34
Iron loading and oxidative stress in theAtm−/−mouse liver
McDonald, C. J., Ostini, L., Wallace, D. F., John, A. N., Watters, D. J., & Subramaniam, V. N. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00486.2010 · Cited by 32
Redox control of iron regulatory protein 2 stability
Hausmann, A., Lee, J., & Pantopoulos, K. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.036 · Cited by 29
“IRPs are also crucial for maintenance of systemic iron homeostasis [4] and may exert additional iron-independent functions [5,6].”
BackgroundSelf-citationFerroptosis and Its Potential Role in Lung Cancer: Updated Evidence from Pathogenesis to Therapy
Chen, K., Zhang, S., Jiao, J., & Zhao, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s347955 · Cited by 30
“In BALB/c (nu/ nu) mice model of lung cancer, overexpression of transferrin receptor 1 (TFR-1) can accelerate the iron absorption rate of lung cancer cells, promote tumor growth, and shorten the mice survival time.(61) Moreover, heat shock protein B 1 (HSPB1) is a negative regulator of ferroptosis as it inhibits the a…”
BackgroundZhu, T., Xiao, Z., Yuan, H., Hu, T., Chen, T., Chen, Q., Chen, M., Jiankun, Y., Zhou, Q.-Z., Guo, W., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.929838 · Cited by 31
“In human lung cancer cells, IRP1 overexpression significantly reduced the capacity of cancer cells to form tumor xenografts in nude mice (19).”
BackgroundValdés, A., García‐Cañas, V., Pérez-Sánchez, A., Barrajón‐Catalán, E., Ruiz-Torres, V., Artemenko, K. A., Micol, V., Bergquist, J., & Cifuentes, A. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.03.072 · Cited by 26
“On the other side, it has also been demonstrated that the overexpression of the ACO1/IRP1 RNA-binding form can suppress tumor growth in xenograft models [41].”
BackgroundSeçgin, Z., Uluışık, S., Yıldırım, K., Abdulla, M. F., Mostafa, K., & Kavas, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213963 · Cited by 22
“IRP1 can recognize the RNA stem-loop structure of iron-responsive elements, localizes to the 5′ untranslated regions of ferritin mRNA, and inhibits ferritin translation [10].”
BackgroundPang, Y. K., Gupta, G., Yang, C., Wang, H., Huynh, T., Abdullaev, Z., Pack, S., Percy, M. J., Lappin, T. R. J., Zhuang, Z., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4127-x · Cited by 21
“planted with IRP1-transfected HI299 lung cancer cells [26].”
BackgroundLan, Y., Yang, T., Yue, Q., Wang, Z., Zhong, X., Luo, X., Zuo, B., Zhang, M., Zeng, T., Liu, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107377 · Cited by 28
“Previous investigators found that overexpressed IRP1was associated with a pronounced tumor suppressor phenotype and provided a direct regulatory link between the IRE/ IRP system and cancer.(36) By analyzing the survival prognosis of glioma patients in TCGA database, we found that glioma patients with high expression o…”
Iron regulatory proteins: players or pawns in ferroptosis and cancer?
Cardona, C. J., & Montgomery, M. R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1229710 · Cited by 24
“As mentioned above, increased expression of TFRC is typically mediated by increased IRP mRNA binding activity, but overexpression of IRP1 was actually found to decrease tumor growth in vivo (Chen et al., 2007).”
BackgroundCasarrubea, D., Viatte, L., Hallas, T., Vasanthakumar, A., Eisenstein, R. S., Schümann, K., Hentze, M. W., & Galy, B. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1008-2 · Cited by 24
“Interestingly, lack of FTL repression in a context of high IRP1 activity has been observed before [26–29] and could possibly be explained by cap-independent translation via the internal ribosomal entry site recently found in the 5′UTR of FTL mRNA [30].”
BackgroundAlternative ferritin mRNA translation via internal initiation
Daba, A., Koromilas, A. E., & Pantopoulos, K. (2012) · RNA · doi:10.1261/rna.029322.111 · Cited by 17
Self-citationIron absorption and distribution in TNFΔARE/+ mice, a model of chronic inflammation
Schümann, K., Herbach, N., Kerling, C., Seifert, M., Fillebeen, C., Prysch, I., Jg, R., Weiß, G., & Pantopoulos, K. (2009) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2009.10.002 · Cited by 17
Self-citationRETRACTED ARTICLE: Ferroportin in the progression and prognosis of hepatocellular carcinoma
Wang, Q., Zhou, J., Zhong, D., Wang, Q., & Huang, J. (2013) · European journal of medical research · doi:10.1186/2047-783x-18-59 · Cited by 15
“Moreover, modulation of iron-regulatory proteins can affect the growth of lung tumor xenografts [12,13].”
BackgroundRetractedInsights on Regulation and Function of the Iron Regulatory Protein 1 (IRP1)
Wang, J., Chen, G., Filebeen, C., & Pantopoulos, K. (2008) · Hemoglobin · doi:10.1080/03630260701680326 · Cited by 15
“A) and B): growth rates of parent H1299 cells and of cells overexpressing IRP1C437S and IRP1wt in culture, and upon injection into nude mice, respectively; C) representative images of anesthetized mice bearing tumor xenografts prior to sacrifice; D) and E): tumor mass and volume, respectively, determined after sacrifi…”
MethodSelf-citationRethinking IRPs/IRE system in neurodegenerative disorders: Looking beyond iron metabolism
Yao, Z., Fu, L., Jia, F., Bi, M., Jiao, Q., Chen, X., Du, X., & Jiang, H. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101511 · Cited by 12
Connor, J. R., & Lee, S. Y. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-627-6_21 · Cited by 11
Cellular Iron Metabolism – The IRP/IRE Regulatory Network
Joshi, R. S., Moran, E. L., & Sánchez, M. (2012) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/34987 · Cited by 11
“The over-expression of IRP1 suppresses growth of tumour xenografts in nude mice (Chen et al., 2007).”
BackgroundRakhmanova, T. I., Sekova, V. Y., Gessler, N. N., Isakova, E. P., Deryabina, Y. I., Попова, Т. Н., Shurubor, Y. I., & Krasnikov, B. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087670 · Cited by 3
Emerging dual role of ferroptosis in lung cancer (Review)
Wu, A., Ni, Y., Zhou, Y. L., & Shi, J. (2025) · Oncology Reports · doi:10.3892/or.2025.8974 · Cited by 6
“In a BALB/c mouse model of LC, overexpression of TFR1 acceler‑ ates tumor growth, decreases survival time and enhances iron uptake by LC cells (59).”
A role for deferasirox as an anti-neoplastic and chemosensitising agent in gastrointestinal cancer
Bedford, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Are there risks for use of iron in cancer patients?
Gascón, P. (2008) · Springer eBooks · doi:10.1007/978-3-211-69459-6_27
Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
Wang, Q., Zhou, J., Zhong, D., Wang, Q., & Huang, J. (2015) · European journal of medical research · doi:10.1186/s40001-015-0132-6
Davis, C. F., & Dorak, M. T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6752-7_17
“growth (Chen et al., 2007).”
Peculiarity of iron metabolism and its role in carcinogenesis processes
Lugovskiy, S. P., Lubyanova, I. P., & Klymenko, P. P. (2013) · Ukrainian Journal of Occupational Health · doi:10.33573/ujoh2013.02.055 · Cited by 3
Iron and the lung: emerging roles of iron metabolism in pulmonary disease pathogenesis and therapy
Galaris, A., Toumpanakis, D., Galaris, D., Vassilakopoulos, T., & Pantopoulos, K. (2026) · European Respiratory Review · doi:10.1183/16000617.0160-2026
“Emerging evidence also implicates iron regulatory proteins: IRP1 overexpression suppresses, whereas IRP2 overexpression promotes tumour growth in xenograft models [142, 143].”
Self-citation
Metadata
- Authors
- Chen, G., Fillebeen, C., Wang, J., & Pantopoulos, K.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10-09
- Volume
- 28
- Issue
- 4
- Pages
- 785-791
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- PMC
- PMC2925110
- OpenAlex
- W2132495634
- Cited by
- 55
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 4 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 3
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (67165)
- Lady Davis Institute for Medical Research
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron regulatory protein 1, iron homeostasis, xenograft tumor growth, tumor suppression, iron-responsive element, transferrin receptor 1, ferritin, ferroportin, H1299 cells, post-transcriptional regulation, iron metabolism
- MeSH terms
- Aconitate Hydratase, Animals, Female, Ferritins, Gene Expression Regulation, Humans, Iron, Lung Neoplasms, Mice, Inbred BALB C, Mice, Nude, Mutation, Spectrophotometry, Atomic, Transplantation, Heterologous, Tumor Cells, Cultured, Blotting, Western, Up-Regulation, Electrophoretic Mobility Shift Assay, Iron Regulatory Protein 1, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.